Exosome Diagnostic and Therapeutics Market Report 2025 (Global Edition)

Global Exosome Diagnostic and Therapeutics Market Report 2025 Market Size Split by Product & Service Type (Instruments, Kits & Reagents, Software, Others), by Application (Diagnostic, Therapeutic), by...

Exosome Diagnostic and Therapeutics Market Report Description

We have various report editions of Exosome Diagnostic and Therapeutics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Exosome Diagnostic and Therapeutics Market Insights Video

Competitive Landscape of the Exosome Diagnostic and Therapeutic Market

The market for exosome diagnostics and therapeutics is very competitive, with both well-established companies and up-and-coming biotechnology startups. Important businesses are concentrating on technology developments in the areas of characterisation, application development, and exosome separation. Combining forces strategically, expanding product lines, and strengthening market positions are frequent tactics.

August 2023: Evox Therapeutics announced a research collaboration with the Icahn School of Medicine to develop exosome encapsulated AAV vectors as a novel gene delivery technology to improve the treatments for heart disease. (Source: https://pharmatimes.com/news/evox_therapeutics_reaches_gene_therapy_agreement_1495926/#:~:text=Evox%20Therapeutics%2C%20an%20exosome%20therapeutics,improving%20therapies%20for%20heart%20disease.) June 2023: Sartorius announced the extension of strategic collaboration agreement with RoosterBio to address the purification challenges and strengthen scalable downstream manufacturing processes for exosome-based therapies. (Source: https://www.sartorius.com/en/company/newsroom/product-news/sartorius-collaborates-with-roosterbio-to-advance-downstream-purification-processes-for-the-manufacture-of-exosomes-1350532)

Top Companies Market Share in Exosome Diagnostic and Therapeutics Industry: (In no particular order of Rank)

• Bio-Techne
• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• System Biosciences
• LLC
• Evox Therapeutics Ltd.
• Capricor Therapeutics
• Inc.
• Codiak BioSciences
• Others
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Exosome Diagnostic and Therapeutic Market

Which Region Dominates the Exosome Diagnostic and Therapeutic Market in 2024?

According to Cognitive Market Research, the exosome diagnostic and therapeutic market is anticipated to be dominated by North America in 2024. The leadership of this area is fueled by elements including significant R&D expenditures in healthcare, cutting-edge biotechnology infrastructure, and a robust presence of major industry players. The quick uptake of novel therapeutic and diagnostic technologies, such as exosome-based treatments, is facilitated by favorable legislative frameworks and high healthcare costs. As these technologies develop and become more widely accepted in medical applications, North America is expected to continue growing as a leading market for exosome diagnostics and therapeutics. This is due to the region's proactive approach to incorporating new healthcare technologies into clinical practice.

Which Region is Expanding at the Fastest CAGR?

The market for exosome diagnostics and therapeutics is growing at the fastest Compound Annual Growth Rate (CAGR) in Asia-Pacific. The region's growing healthcare infrastructure, rising chronic illness prevalence, and expanding healthcare expenditures are all driving this increase. An atmosphere that is favorable for market development is being created by government programs that are encouraging and intended to increase innovation in biotechnology and healthcare. The region's fast expansion in exosome-based diagnostics and therapies is partly due to the increased use of customized medicine and technical breakthroughs. It is anticipated that Asia-Pacific will see major advancements and become a key participant in the global exosome diagnostic and therapeutic landscape as it continues to invest in healthcare technology and strengthen regulatory frameworks.

The current report Scope analyzes Exosome Diagnostic and Therapeutics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Exosome Diagnostic and Therapeutics Market Analysis

According to Cognitive Market Research, the global Exosome Diagnostic and Therapeutic market size was estimated at USD 228.9 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 91.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 28.8% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the exosome diagnostic and therapeutic market with a market size of USD 72.24 million in 2024 and is projected to grow at a CAGR of 28.6% during the forecast period. Leading in exosome market due to high healthcare spending and advanced biotechnology.
• The Canada exosome diagnostic and therapeutic market had a market share of USD 10.99 million in 2024 and is projected to grow at a CAGR of 29.9% during the forecast period. Focus on sustainability and technological innovation fuels market expansion.
• The Mexico exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 29.3% during the forecast period, with a market size of USD 8.33 million in 2024.

Europe Exosome Diagnostic and Therapeutics Market Analysis

According to Cognitive Market Research, the global Exosome Diagnostic and Therapeutic market size was estimated at USD 228.9 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 68.67 million in 2024 and will grow at a compound annual growth rate (CAGR) of 29.1% from 2024 to 2031.

• The United Kingdom exosome diagnostic and therapeutic market had a market share of USD 11.54 million in 2024 and is projected to grow at a CAGR of 29.9% during the forecast period. Stringent environmental policies and sustainability goals propel market growth.
• The France exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 28.3% during the forecast period, with a market size of USD 6.32 million in 2024.
• According to Cognitive Market Research, the Germany Exosome Diagnostic and Therapeutic market size was valued at USD 13.60 million in 2024 and is projected to grow at a CAGR of 29.3% during the forecast period. Strong emphasis on recycling and advanced technology adoption spurs market expansion.
• The Italy exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 28.5% during the forecast period, with a market size of USD 5.91 million in 2024.
• The Russia exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 28.1% during the forecast period, with a market size of USD 10.64 million in 2024.
• The Spain exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 28.2% during the forecast period, with a market size of USD 5.63 million in 2024.
• The Luxembourg exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 29.2% during the forecast period, with a market size of USD 2.13 million in 2024.
• The Portugal exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 28.9% during the forecast period, with a market size of USD 1.44 million in 2024.
• The Greece exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 29.4% during the forecast period, with a market size of USD 0.82 million in 2024.
• The Rest of Europe Exosome Diagnostic and Therapeutic market is projected to witness growth at a CAGR of 27.8% during the forecast period, with a market size of USD 10.64 million in 2024.

Asia Pacific Exosome Diagnostic and Therapeutics Market Analysis

According to Cognitive Market Research, the global Exosome Diagnostic and Therapeutic market size was estimated at USD 228.9 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 52.65 million in 2024 and will grow at a compound annual growth rate (CAGR) of 32.6% from 2024 to 2031.

• According to Cognitive Market Research, the China Exosome Diagnostic and Therapeutic market size was valued at USD 23.69 million in 2024 and is projected to grow at a CAGR of 32.1% during the forecast period. Rapid urbanization and industrialization fuel demand for waste management solutions.
• The Japan exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 31.1% during the forecast period, with a market size of USD 7.27 million in 2024.
• The India Exosome Diagnostic and Therapeutic market had a market share of USD 6.32 million in 2024 and is projected to grow at a CAGR of 34.4% during the forecast period. Increasing urbanization and government initiatives drive market growth.
• The South Korea exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 31.7% during the forecast period, with a market size of USD 5.26 million in 2024.
• The Australia exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 32.3% during the forecast period, with a market size of USD 2.74 million in 2024.
• The South East Asia exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 33.6% during the forecast period, with a market size of USD 3.63 million in 2024.
• The Rest of the APAC Exosome Diagnostic and Therapeutic market is projected to witness growth at a CAGR of 32.4% during the forecast period, with a market size of USD 3.74 million in 2024.

South America Exosome Diagnostic and Therapeutics Market Analysis

According to Cognitive Market Research, the global Exosome Diagnostic and Therapeutic market size was estimated at USD 228.9 Million out of which the Latin America market of more than 5% of the global revenue with a market size of USD 11.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 30.0% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Exosome Diagnostic and Therapeutic market size was valued at USD 4.90 million in 2024 and is projected to grow at a CAGR of 30.6% during the forecast period. Exosome Diagnostic and Therapeutic sales flourish in Brazil due to the rising labor costs incentivize adoption of ASRS for labor-saving.
• Argentina's Exosome Diagnostic and Therapeutic market had a market share of USD 1.92 million in 2024 and is projected to grow at a CAGR of 30.9% during the forecast period. Argentina's technological advancements augment the demand to drive innovation in the logistics industry.
• The Colombia exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 29.8% during the forecast period, with a market size of USD 1.02 million in 2024.
• The Peru exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 30.2% during the forecast period, with a market size of USD 0.94 million in 2024.
• The Chile exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 30.3% during the forecast period, with a market size of USD 0.82 million in 2024.
• The Rest of LATAM Exosome Diagnostic and Therapeutic market is projected to witness growth at a CAGR of 29.1% during the forecast period, with a market size of USD 1.84 million in 2024.

Middle East Exosome Diagnostic and Therapeutics Market Analysis

According to Cognitive Market Research, the global Exosome Diagnostic and Therapeutic market size was estimated at USD 228.9 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 4.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 30.3% from 2024 to 2031.

• The GCC Countries exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 31.1% during the forecast period with a market size of USD 1.96 million in 2024. Infrastructure development and urbanization accelerate market growth.
• The Egypt exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 30.6% during the forecast period, with a market size of USD 0.48 million in 2024
• The South Africa exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 31.3% during the forecast period, with a market size of USD 0.72 million in 2024. Government initiatives and infrastructure investments propel market expansion.
• The Turkey exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 29.8% during the forecast period, with a market size of USD 0.39 million in 2024.
• The Nigeria exosome diagnostic and therapeutic market is projected to witness growth at a CAGR of 29.4% during the forecast period, with a market size of USD 0.48 million in 2024.
• The Rest of MEA Exosome Diagnostic and Therapeutic market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 9.74 million in 2024.

Exosome Diagnostic and Therapeutics Market Analysis

Exosome Diagnostic and Therapeutic Market Product Type Segment Analysis

According to Cognitive Market Research, the Instrument sector holds the most market share in the exosome diagnostic and therapeutic market. Tools are essential for the extraction, description, and examination of exosomes, promoting progress in medical diagnosis and treatment. Because these advanced equipment can yield accurate and dependable data on exosome characteristics, there is an increasing demand for them, including flow cytometers and high-resolution microscopes. The performance and precision of these instruments are being improved by the ongoing development of novel technologies, such as nanoparticle tracking analysis (NTA) systems and microfluidic devices. The use of cutting-edge equipment is being fueled by an increase in research activities and clinical trials concentrating on exosome-based diagnostics and therapeutics, which is solidifying their market dominance.

In the market for exosome diagnostics and therapeutics, the reagent sector is growing quickly. Reagents are becoming more and more in demand due to their importance in the many stages of exosome separation, characterisation, and analysis. The precision and efficiency of exosome studies are being improved by the introduction of proteomics reagents, nucleic acid separation kits, and high-specificity antibodies. The need for uniform testing techniques and an increased emphasis on biomarker development are driving up demand for specialized reagents. Reagents are essential to the creation and commercialization of exosome-based diagnostics and treatments as they are driving the rise of research and clinical applications in personalized medicine and regenerative therapies.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Exosome Diagnostic and Therapeutics Industry. Request a Free Sample PDF!

Exosome Diagnostic and Therapeutic Market Application Segment Analysis

According to Cognitive Market Research, the exosome market's diagnostic sector now has a leading position due to its vital function in non-invasive illness detection and monitoring. By analyzing physiological fluids for biomarkers, exosome-based diagnostics might detect illnesses like cancer and neurological disorders early on. This method improves overall illness management and treatment results by increasing patient comfort and enabling frequent monitoring. The diagnostic sector gains from continuous developments in exosome characterisation and separation technologies, which make more precise and sensitive detection techniques possible. Exosomes' diagnostic potential is growing as a result of increased research collaborations and funding, reaffirming its role as a key component of early illness detection.

The exosome market is expanding at the quickest rate in the therapeutic category due to advancements in regenerative medicine and medication delivery. Exosomes are naturally occurring nanocarriers that may be used to transport therapeutic materials to target cells, including medicines, proteins, and RNA. This process has the benefit of increased bioavailability, less side effects, and greater effectiveness. In oncology, this field is especially promising since exosome-based medicines have the potential to be used in customized medicine and targeted cancer treatment. Encouraged by continuing research and clinical trials, the therapeutic use of exosomes is also spreading into fields such as immune regulation, wound healing, and tissue regeneration. Exosome-based treatments are being improved by biotechnological developments, therefore this market is expected to increase significantly and be widely used in a variety of therapeutic contexts.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Exosome Diagnostic and Therapeutics End User Segment Analysis

End User Segment Analysis

According to Cognitive Market Research, given their status as key sites for patient care and diagnostics, hospitals constitute the leading end user group in the exosome diagnostic and therapeutic market. Exosome-based diagnostics helps hospitals identify diseases more quickly and accurately while providing patients with non-invasive testing choices. The organization's vast infrastructure and seamless connection with healthcare systems allow the effective implementation of cutting-edge technology, such as instruments for isosome separation and analysis. Additionally, hospitals are essential locations for exosome-based therapeutic applications since they make patient monitoring and therapy administration easier. Hospitals dominate this market category because they may use exosome technologies to treat a variety of medical diseases, which leads to significant market growth and demand.

In the market for exosome diagnostics and therapeutics, cancer institutions are emerging as the fastest-growing category. These specialist institutions are perfect for implementing cutting-edge technologies like exosome-based diagnostics since they concentrate a great deal on cancer research, diagnosis, and therapy. Exosome biomarkers are used by cancer institutes to track therapy responses, diagnose cancer early, and create individualized treatment regimens. Their commitment to cancer research and patient care encourages exosome technologies to be adopted quickly, which propels market expansion. Partnerships between biotechnology companies and oncology institutions spur research in exosome-based therapies with the goal of enhancing cancer patients' outcomes after therapy. Cancer institutions are positioned to have a significant influence on the direction of exosome diagnostics and treatments as long as they maintain and grow their infrastructure and skills.

• Hospitals & Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Diagnostic Laboratories
• Others

Author's Detail

Ankita Sharma

Senior Research Analyst at Cognitive Market Research

LinkedIn

Profile

Ankita Sharma is a passionate and detail-driven market research professional with over 2.5 years of experience in qualitative research. With a sharp focus on client query handling and competitive intelligence, she has successfully led and delivered impactful research projects across diverse industry verticals. At the core of Ankita’s work is her ability to transform complex market data into actionable insights. She has spearheaded market intelligence initiatives by analyzing trends, evaluating competitor strategies, and mapping evolving market dynamics using a range of industry tools. Her approach combines precision with adaptability ensuring research outcomes are tailored to client-specific needs and strategic goals.
Ankita is also skilled in secondary research and product benchmarking, offering a holistic view of competitive landscapes. Her collaborative spirit and cross-functional coordination have helped refine research methodologies and maintain the highest quality standards in deliverables. Ankita’s commitment to excellence and client success makes her a valuable asset in the evolving world of market intelligence and business strategy.

Author's Conclusion